Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MaxWin International HoldingsHKSE:08513 -1.35%53 PS Ratio is 0.27 as of Sep. 03, 2026, which is 80% below its 10-year median of 1.37. GuruFocus rates HKSE:08513 with a GF Score™ of 53/100 and a GF Value™ of HK$1.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 803 Medical Devices & Instruments companies, MaxWin International Holdings ranks better than 95.89% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MaxWin International Holdings's share price is HK$0.365.
MaxWin International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.38. Hence, MaxWin International Holdings's PS Ratio for today is 0.27.
The historical rank and industry rank for MaxWin International Holdings's PS Ratio or its related term are showing as below:
HKSE:08513'
s PS Ratio Range Over the Past 10 Years
Min: 0.22 Med: 1.37 Max: 15.44
Current: 0.27
During the past 11 years, MaxWin International Holdings's highest PS Ratio was 15.44. The lowest was 0.22. And the median was 1.37.
HKSE:08513's PS Ratio is ranked better than 95.89% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.97
vs HKSE:08513: 0.27
MaxWin International Holdings Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of MaxWin International Holdings was 68.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -19.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -8.40% per year.
During the past 11 years, MaxWin International Holdings's highest 3-Year average Revenue per Share Growth Rate was 7.00% per year. The lowest was -30.70% per year. And the median was -2.95% per year.
MaxWin International Holdings (HKSE:08513) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
MaxWin International Holdings PS Ratio Related Terms
MaxWin International Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, MaxWin International Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MaxWin International Holdings PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MaxWin International Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where MaxWin International Holdings's PS Ratio falls into.
MaxWin International Holdings PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
MaxWin International Holdings's Share Price of today is HK$0.365.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MaxWin International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.38.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
MaxWin International Holdings (HKSE:08513) has a PS Ratio of 0.27 as of Sep. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MaxWin International Holdings and its competitors. This is 80% below median its historical median of 1.37. Over the past decade, MaxWin International Holdings' PS Ratio has ranged from 0.22 to 15.44. According to the industry distribution chart, MaxWin International Holdings ranks #33 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 4.1%.
Is MaxWin International Holdings' PS Ratio too high?
MaxWin International Holdings' current PS Ratio of 0.27 is 80% below median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 15.44. The Medical Devices & Instruments industry median PS Ratio is 2.97. MaxWin International Holdings' value of 0.27 is 90.9% below this industry median. Based on the distribution chart, MaxWin International Holdings ranks #33 out of 803 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MaxWin International Holdings has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MaxWin International Holdings' PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, MaxWin International Holdings ranks #33 out of 803 companies for PS Ratio. This places MaxWin International Holdings in the top 4% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.97. MaxWin International Holdings' value of 0.27 is 90.9% below this benchmark. Historically, MaxWin International Holdings' own PS Ratio has ranged from 0.22 to 15.44 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 2.97, MaxWin International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.97, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MaxWin International Holdings's current PS Ratio of 0.27 is 90.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MaxWin International Holdings and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MaxWin International Holdings's current PS Ratio is 0.27, which is 80% below median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MaxWin International Holdings stock overvalued right now?
Based on GuruFocus' analysis, MaxWin International Holdings (HKSE:08513) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.97, compared to a current price of HK$0.37 — trading 81.5% below its estimated fair value. The current PS Ratio is 0.27, which is 80% below median its 10-year median of 1.37 and 90.9% below the Medical Devices & Instruments industry median of 2.97. MaxWin International Holdings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For MaxWin International Holdings (HKSE:08513), the current PS Ratio is 0.27 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MaxWin International Holdings (HKSE:08513) Overvalued in 2026?
Based on GuruFocus' analysis, MaxWin International Holdings stock appears to be undervalued.
The current stock price of HK$0.37 is trading 81.5% below its estimated GF Value™ of HK$1.97.
GuruFocus considers MaxWin International Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08513:
PS Ratio: 0.27 (80% below median its 10-year median of 1.37)
GF Value™: HK$1.97 vs. price of HK$0.37 (81.5% below fair value)
Industry Position: 90.9% below the Medical Devices & Instruments median (#33 of 803)
No single metric tells the full story. See the HKSE:08513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MaxWin International Holdings Ltd is engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices and the provision of tooling services in Singapore. The group also operates in data solutions and services involving IT-related products and maintenance services, as well as hospitality operations. It has four reportable segments: Component Parts, Sub-assembly Parts, Data Solutions and Services, and Hospitality. It generates the majority of its revenue from the Component Parts segment. Geographically, it generates the majority of its revenue from Mainland China.
53GF Score
Get the complete analysis for HKSE:08513
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08513 has been successfully added to your 
